AGC's Japanese and Danish factories to produce German biotech firm's drug candidate
![In August, AGC broke ground on an expansion of its factory in Hillerød, Copenhagen | Photo: AGC Biologics / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13221596.ece/ALTERNATES/schema-16_9/doc7h7xnfjhl9txwaxieho.jpg)
Contract manufacturing organization AGC Biologics has entered into a partnership with biotech company 4teen4 Pharmaceuticals to produce the latter firm's drug candidate, procizumab, according to an AGC press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.